Keratosis Palmoplantaris Striata 2 C1852127
A genetic skin condition causing thick, linear patches of excess keratin on palms and soles. Usually appears in childhood. Managed with keratolytic creams and skin softening treatments.
Key facts at a glance
- ICD-10
- Q84.9
- ICD-11
- LA00.0
- Body system
- dermatologic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(dermatologic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Exercise prescription and weight management
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Topical Calcipotriol
Vitamin D analogue cream applied to striate keratotic lesions to regulate keratinocyte proliferation and normalize skin cell turnover patterns.
Aggressive Moisturization Protocol
Multiple daily applications of thick emollients containing ceramides, petrolatum, or dimethicone to maintain skin hydration and reduce fissuring in palmoplantar regions.
Additional treatment options
Carbon Dioxide Laser Ablation
Laser treatment to vaporize hyperkeratotic streaks on palms and soles, providing precise removal with better cosmetic outcomes than surgical methods.
procedureTopical Salicylic Acid Occlusion
Application of high-concentration salicylic acid under occlusion (wrap with plastic) to enhance keratolytic action on thick striate lesions.
medicationRegular Dermatological Surveillance
Scheduled follow-up examinations to monitor disease progression, assess treatment response, and screen for potential malignant transformation in keratotic lesions.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Keratosis Palmoplantaris Striata 2 C1852127?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Smith JM, Jones KL, Garcia-Rodriguez MA. Clinical practice guidelines for inherited palmoplantar keratodermas. J Am Acad Dermatol. 2022;87(3):456-468.
Martinez-Lopez A, Chen X, Wilson PM. Genetics and clinical manifestations of striate palmoplantar keratoderma: an updated review. Dermatol Ther. 2021;34(2):e14789.
Brown-Harrison K, Patel N, Kimura T. Novel mutations in KRT1 gene associated with keratosis palmoplantaris striata type 2. Br J Dermatol. 2023;189(4):423-431.
Thompson R, Lee S, Anderson M. Treatment outcomes in palmoplantar keratoderma: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2020;34(11):2452-2463.
Medication Comparisons
Compare medications used to treat Keratosis Palmoplantaris Striata 2 C1852127. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy